KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →
NEWExperts by KevinMDPhysicians and health care experts, by specialty.Shveta GuptaHematology physicianDevin ZarkowskyVascular surgeonKenneth RoInternistEmily WattersPsychiatristAleksandra FilipovicMedical oncologistReuben MathewMed-peds residentRobert MurryFamily physicianKayvan HaddadanPhysiatristPaul HainPediatricianBarbara SparacinoPsychiatristHussain Isma'eelCardiologistAnn LebeckFamily physicianLynn R. WebsterPain medicine physicianAngelika LuehrsConsultant psychiatristBobby DuboisInternistLaurel A. CoonsScientistNathaniel AranaHealth care CEOCraig HaubenHealth care CEOJessica ChalkPatient advocateBrowse experts

Bristol-Myers pursues OTC sales for Pravachol

Bristol-Myers pursues OTC sales for Pravachol

No surprise here. Statins have been OTC in Britain for the past year or so. Incidentally Pravachol is Bristol-Myers’ biggest seller, and its patent will be expiring soon. This is purely money-based – don’t believe anything about “health benefits” that the drug company claiming is behind the move.

Share this articleLinkedInFacebookXEmail

Tagged as: Medications and Prescribing

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.

Keep reading

Latest on KevinMD →

Leave a Comment
KevinMD.com
Bristol-Myers pursues OTC sales for Pravachol